Limitations of Case-Control Studies in Rare Exposure Assessment
Limitations of Case-Control Studies in Rare Exposure Assessment Understanding the Limitations of Case-Control Studies in Rare Exposure Assessment Case-control studies are often favored for their efficiency in examining rare outcomes. However, when applied to assess rare exposures—such as seldom-prescribed medications, environmental toxins, or rare gene variants—they present unique challenges. For pharmaceutical and clinical trial professionals,…
Read More “Limitations of Case-Control Studies in Rare Exposure Assessment” »